WallStreetZenWallStreetZen

NASDAQ: TERN
Terns Pharmaceuticals Inc Stock Ownership - Who owns Terns Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Terns Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Emil KuriakoseChief Medical Officer2025-07-01853$4.27
$3.64kSell
Andrew GengosChief Financial Officer2025-06-275,000$3.93
$19.65kBuy
Andrew GengosChief Financial Officer2025-06-275,000$3.93
$19.64kBuy
Amy L. BurroughsChief Executive Officer2025-06-2523,314$3.87
$90.23kBuy
Andrew GengosChief Financial Officer2025-06-165,000$3.95
$19.73kBuy
Andrew GengosChief Financial Officer2025-06-135,000$3.75
$18.75kBuy
Andrew GengosChief Financial Officer2025-06-135,000$3.72
$18.60kBuy
Emil KuriakoseChief Medical Officer2025-04-01952$2.49
$2.37kSell
Jill M. QuigleyDirector2025-01-068,760$5.79
$50.76kSell
Mark J. VignolaChief Financial Officer2025-01-069,059$5.80
$52.50kSell

1 of 2

TERN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TERN insiders and whales buy or sell their stock.

TERN Shareholders

What type of owners hold Terns Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Opportunity LLC13.18%11,536,701$83.41MInsider
Soleus Capital Management LP9.33%8,167,100$59.05MInstitution
Orbimed Advisors LLC8.64%7,562,971$54.68MInstitution
Deep Track Capital LP8.56%7,495,000$54.19MInstitution
Morgan Stanley8.29%7,253,469$52.44MInstitution
Vivo Capital LLC7.88%6,895,746$49.86MInstitution
Blackrock Inc6.25%5,470,374$39.55MInstitution
Vanguard Group Inc4.92%4,306,166$31.13MInstitution
Citadel Advisors LLC4.46%3,899,011$28.19MInstitution
Schonfeld Strategic Advisors LLC3.49%3,049,891$22.05MInstitution

1 of 3

TERN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TERN80.34%19.66%Net BuyingNet Buying
SVRA40.00%60.00%Net BuyingNet Buying
BCAX70.79%29.21%Net Selling
KROS71.32%28.68%Net BuyingNet Selling
RZLT42.15%57.85%Net BuyingNet Buying
View Top Biotech Stocks

Terns Pharmaceuticals Stock Ownership FAQ

Who owns Terns Pharmaceuticals?

Terns Pharmaceuticals (NASDAQ: TERN) is owned by 94.97% institutional shareholders, 23.24% Terns Pharmaceuticals insiders, and 0.00% retail investors. Vivo Opportunity LLC is the largest individual Terns Pharmaceuticals shareholder, owning 11.54M shares representing 13.18% of the company. Vivo Opportunity LLC's Terns Pharmaceuticals shares are currently valued at $82.26M.

If you're new to stock investing, here's how to buy Terns Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.